Global Corporate Challenge Evaluation: The evaluation of a low-cost, low-impact physical-activity workplace intervention. Societal increases in obesity and physical inactivity have led to consideration of workplace interventions as a potential for improving health. However, long-term evaluations of such interventions are rare. Here we will evaluate the Global Corporate Challenge (GCC), which engages employees to participate in a four month pedometer-based program aimed at increasing their physic ....Global Corporate Challenge Evaluation: The evaluation of a low-cost, low-impact physical-activity workplace intervention. Societal increases in obesity and physical inactivity have led to consideration of workplace interventions as a potential for improving health. However, long-term evaluations of such interventions are rare. Here we will evaluate the Global Corporate Challenge (GCC), which engages employees to participate in a four month pedometer-based program aimed at increasing their physical activity levels. We will follow 1000 participants for two years to determine the short and long-term health benefits of the program and to provide insight into factors that may improve the success of such programs. Such findings are essential for appropriate government and industry policy decisions in this area of chronic disease prevention. Read moreRead less
Planning female and male vaccination and cervical screening strategies to achieve optimal prevention of HPV-related disease. The findings from this research will inform the development of public health policy on the most cost-effective utilisation of resources for preventing cervical, anogenital and head/neck cancers, and genital warts, in women and men, due to human papillomavirus (HPV). We will evaluate strategies for using emerging screening and vaccine technologies to prevent HPV-related dis ....Planning female and male vaccination and cervical screening strategies to achieve optimal prevention of HPV-related disease. The findings from this research will inform the development of public health policy on the most cost-effective utilisation of resources for preventing cervical, anogenital and head/neck cancers, and genital warts, in women and men, due to human papillomavirus (HPV). We will evaluate strategies for using emerging screening and vaccine technologies to prevent HPV-related disease, and assess potential adverse outcomes of vaccination. Men are currently not covered by routine vaccination or screening programs; this research will assess the benefit to men of vaccinating women only, and will consider the impact of vaccination and other interventions targeted towards men.Read moreRead less
Cancer Risks From Low-dose Ionising Radiation Following Diagnostic Medical Procedures
Funder
National Health and Medical Research Council
Funding Amount
$750,579.00
Summary
Our study investigates cancer risk following exposure to low doses of ionising radiation from medical procedures. Our first major paper linked over 800,000 CT exposures to cancer outcomes in a cohort of almost 11 million young Australians, and found that CT exposure predicted an increased incidence of leukaemia and most solid cancers. In our ongoing work we will incorporate nuclear medicine and other diagnostic x-rays, and estimate radiation dose for individual procedures and to specific organs.
Environmental Risk Factors For Iron Overload-related Disease In A Cohort Study Of Hereditary Haemochromatosis
Funder
National Health and Medical Research Council
Funding Amount
$152,936.00
Summary
Results published last year from our Melbourne HealthIron study of hereditary haemochromatosis (iron overload disease) show that almost one third of the 50,000 men genetically at risk of iron overload in Australia will develop symptoms of disease including fatigue, arthritis and liver damage. We will use data from the recent follow-up of the Health2020 cohort, of which HealthIron is a sub-study, to determine environmental risk factors for progression to disease in people with iron overload.